HCP, Inc. (HCP) Announces $0.37 Quarterly Dividend

Share on StockTwits

HCP, Inc. (NYSE:HCP) announced a quarterly dividend on Thursday, October 25th, RTT News reports. Shareholders of record on Monday, November 5th will be given a dividend of 0.37 per share by the real estate investment trust on Tuesday, November 20th. This represents a $1.48 dividend on an annualized basis and a yield of 5.37%. The ex-dividend date of this dividend is Friday, November 2nd.

HCP stock opened at $27.55 on Thursday. The company has a debt-to-equity ratio of 1.37, a quick ratio of 0.51 and a current ratio of 0.51. HCP has a twelve month low of $21.48 and a twelve month high of $27.91. The company has a market cap of $12.85 billion, a price-to-earnings ratio of 14.13, a P/E/G ratio of 6.87 and a beta of 0.28.

HCP (NYSE:HCP) last released its quarterly earnings data on Wednesday, October 31st. The real estate investment trust reported $0.21 earnings per share for the quarter, topping analysts’ consensus estimates of $0.11 by $0.10. HCP had a net margin of 3.39% and a return on equity of 1.12%. The company had revenue of $456.00 million for the quarter, compared to analysts’ expectations of $456.59 million. During the same quarter last year, the company earned $0.48 earnings per share. The firm’s revenue for the quarter was up .4% on a year-over-year basis. As a group, analysts predict that HCP will post 1.82 earnings per share for the current year.

A number of research firms have weighed in on HCP. BMO Capital Markets reissued a “hold” rating and set a $27.00 price objective on shares of HCP in a report on Wednesday. JPMorgan Chase & Co. lowered shares of HCP from an “overweight” rating to a “neutral” rating in a research report on Friday, October 5th. Cantor Fitzgerald upgraded shares of HCP from a “neutral” rating to an “overweight” rating and raised their target price for the stock from $28.00 to $29.00 in a research report on Thursday, September 27th. Bank of America raised their target price on shares of HCP from $27.50 to $28.00 and gave the stock a “buy” rating in a research report on Monday, September 17th. Finally, Morgan Stanley raised their target price on shares of HCP from $23.50 to $25.00 and gave the stock an “equal weight” rating in a research report on Thursday, August 16th. Two investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and four have given a buy rating to the stock. HCP presently has an average rating of “Hold” and a consensus target price of $26.68.

About HCP

HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.

Further Reading: What Does Beta Mean In Stock Selection

Dividend History for HCP (NYSE:HCP)

Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply